No black box warning on record for Vilazodone Hydrochloride

As of the latest FDA labeling reviewed, Vilazodone Hydrochloride (VILAZODONE HYDROCHLORIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Vilazodone Hydrochloride medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents (e.g., SSRI, SNRI, triptans, amphetamines), but also when taken alone. If it occurs, discontinue vilazodone hydrochloride tablets and initiate supportive treatment (5.2). • Increased Risk of Bleeding: Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), other an

No black box warning on record for Vilazodone Hydrochloride

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Serotonin Syndrome: Increased risk when co-administered with other serotonergic agents (e.g., SSRI, SNRI, triptans, amphetamines), but also when taken alone. If it occurs, discontinue vilazodone hydrochloride tablets and initiate supportive treatment (5.2). • Increased Risk of Bleeding: Concomitant use of aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), other an

Vilazodone Hydrochloride Black Box Warning

No black box warning on record for Vilazodone Hydrochloride

Other warnings & precautions

Vilazodone Hydrochloride Black Box Warning

No black box warning on record for Vilazodone Hydrochloride

Other warnings & precautions